Home Siegfried

Siegfried

In operation
IPO
Active Pharmaceutical Ingredient (API) Research, Development, and Manufacturing

Basic Information

Siegfried, as an internationally renowned outsourcing partner, provides products and customized service packages that can be seamlessly integrated into customers' value chains. Our pharmaceutical industry partners benefit from a wide range of product development active substances, ready-to-use drug development services, approval and production, as well as packaging and logistics. As a formerly fully integrated pharmaceutical company, Siegfried develops and produces active pharmaceutical ingredients for pharmaceutical clients through R&D projects, related intermediates, and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile filling.Siegfried's R&D and production sites are located in Switzerland, the United States, Malta, China, Germany, France, and Spain. The company currently has approximately 3,500 employees and achieved sales of 845.1 million Swiss francs in the 2020 fiscal year.
Siegfried Holding AG
Aargau,Switzerland
more than 500 people
January 01, 1873
info@siegfried.ch